Please login to the form below

Not currently logged in
Email:
Password:

interactive

This page shows the latest interactive news and features for those working in and with pharma, biotech and healthcare.

Bayer looks to leverage AI across the pharma value chain

Bayer looks to leverage AI across the pharma value chain

Digital intelligence blog. Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools.

Latest news

More from news
Approximately 3 fully matching, plus 841 partially matching documents found.

Latest Intelligence

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Online learning platforms with interactive and engaging content can quickly provide audiences with key information, and Independent Medical Education activities offer a route to inform HCPs on broad aspects of rare

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Online learning platforms with interactive and engaging content can quickly provide audiences with key information, and Independent Medical Education activities offer a route to inform HCPs on broad aspects of rare

  • The new rules of marketing and PR The new rules of marketing and PR

    Yet 64% of hospital marketing departments devote less than 25% of their marketing budgets to interactive content. ... Even more telling is how hospital marketers spend their time: 83% of hospitals devote less than 30% of staff time to interactive media.

  • Integrating digital biomarkers into precision medicine Integrating digital biomarkers into precision medicine

    Increasingly, through the use of innovative devices such as portables, wearables, interactives, implantables and ingestibles, life science companies are looking to use ‘digital biomarkers’to measure physiological, cognitive or behavioural

  • Patient recruitment and engagement standards Patient recruitment and engagement standards

    The Harris Interactive Survey shows that 85% of patients were either unaware or unsure that participation in a clinical trial was a viable option available at the time of their diagnosis.

More from intelligence
Approximately 0 fully matching, plus 38 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 12 fully matching, plus 152 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics